<DOC>
	<DOCNO>NCT02609867</DOCNO>
	<brief_summary>The purpose study evaluate safety short-term effectiveness implantation 'Flowise Cerebral Flow Diverter ' treatment unruptured wide-necked cerebral aneurysm internal carotid artery .</brief_summary>
	<brief_title>A Feasibility Study Evaluate Safety Effectiveness Implantation Flowise Cerebral Flow Diverter ( Flowise )</brief_title>
	<detailed_description>Flowise indicate use patient unruptured wide-necked aneurysm internal carotid artery . Consecutive subject data collect discharge , 1 , 3 , 6 month post Flowise implantation .</detailed_description>
	<mesh_term>Aneurysm</mesh_term>
	<mesh_term>Intracranial Aneurysm</mesh_term>
	<criteria>Functional neurological state ≤2 mRS Unruptured wideneck aneurysm internal carotid artery size &gt; 8mm , neck ≥4mm , dome/neck ratio &lt; 2 Parent artery diameter ≥3.25mm ≤4.5mm Patient willing provide write informed consent comply followup requirement Intracranial hemorrhage within 30 day Untreated ruptured intracranial aneurysm ≥1 intracranial aneurysm except target one require treatment within 6 month Immunosuppressive disease Active infectious disease ( e.g . endocarditis , meningitis ) Platelet count &lt; 100 x 103 cells/mm3 Female childbearing potential unable take adequate contraceptive precaution , know pregnant , currently breastfeed infant .</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>